Identification of the significant role of BIRC6 in cancer progression and response to treatment has resulted in the suggestion of BIRC6 as a novel target for anticancer therapy in different cancers, such as prostate cancer [ 12, 25- 26]. Here, BIRC6 is linked to prostate carcinoma.